GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Other Current Liabilities

Belite Bio (Belite Bio) Other Current Liabilities : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Other Current Liabilities?

Belite Bio's other current liabilities for the quarter that ended in Mar. 2024 was $0.00 Mil.

Belite Bio's quarterly other current liabilities increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.88 Mil) but then declined from Dec. 2023 ($0.88 Mil) to Mar. 2024 ($0.00 Mil).

Belite Bio's annual other current liabilities increased from Dec. 2021 ($0.15 Mil) to Dec. 2022 ($0.46 Mil) and increased from Dec. 2022 ($0.46 Mil) to Dec. 2023 ($0.88 Mil).


Belite Bio Other Current Liabilities Historical Data

The historical data trend for Belite Bio's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Other Current Liabilities Chart

Belite Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
- - - -

Belite Bio Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Belite Bio Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Belite Bio Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Belite Bio's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Belite Bio (Belite Bio) Business Description

Traded in Other Exchanges
Address
12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.